GMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd

Size: px
Start display at page:

Download "GMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd"

Transcription

1 GMP Compliance George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd June 2017

2 Overview GMP Definition and Regulation Our Philosophy and Strategy for Compliance Project Lifecycle Deliverables Master Plan and Flow Qualification Protocols Summary

3 Good Manufacturing Practice (GMP) Manufacturing of medicinal products shall be undertaken in accordance with the principles of Good Manufacturing Practice (GMP) which is governed by the Health Authority within the products market intent. Definition. There should be written procedure and the associated records of action taken or conclusion reached, where appropriate, for validation, equipment assembly & calibration, maintenance PICS PE activities undertaken to demonstrate that utilities and pieces of equipment are suitable for their intended use and perform properly FDA guidance for Industry Process Validation: General Principles and Practices, Jan 2011.

4 GMP Regulation Country / Region Authority GMP Guidelines Australia TGA (Therapeutic Goods Administration) PIC/S Canada Health Products and Food Branch Inspectorate ( HPFBI ) PIC/S China SFDA (State Food and Drug Administration) WHO / SFDA GMP European EMA (European Medicines Agency) EudraLex India CDSCO (Central Drugs Standard Control Organization) Indonesia NA-DFC (National Agency of Drug and Food Control) PIC/S WHO Japan PMDA (Pharmaceuticals Medicines & Drugs Agency) MHLW (Ministry of Health Labor and Welfare) / PIC/S Malaysia NPRA (National Pharmaceutical Regulatory Body) PIC/S New Zealand Medsafe PIC/S Singapore HSA (Health Sciences Authority) PIC/S Thailand Thai FDA ( Food and Drug Administration ) WHO / PIC/S US (United States) US FDA (Food and Drug Authority) 21 CFR / PIC/S UK (United Kingdom) United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) Vietnam Ministry of Health WHO PIC/S

5 What is GMP compliance? The aim of the GMP standard is to ensure medicinal products are consistently produced to the quality standards appropriate for their intended use. This standard is defined as being within specifications of strength, quality and purity and without adulteration. It is designed to minimise the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. Main risks are : unexpected contamination of products incorrect labels on containers, which could result in patients being prescribed the wrong medicine insufficient or too much active ingredient, resulting in ineffective treatment or adverse effects due to incorrect dosage

6 What is GMP compliance? Common GMP requirements include The establishment and maintenance of an effective quality assurance system Adequate process control. Suitably qualified, trained and supervised employees. Premises and equipment that has been located, designed, installed, operated and maintained to suit intended operations. Maintenance of a documentation system comprising of adequate records which detail all critical aspects of the process. Appropriate measures to minimise the ingress of contamination into the product from any external source, in particular from components, environment, premises and equipment. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff.

7 GMP Compliance Strategies Involve CQV representative from DAY ONE (e.g. RFP stage). Formal documented GMP reviews will be conducted at an early stage of the project Combined commissioning and validation approach that optimises the schedule and integration activities Define process flow, procedure and template with the client. Production of high quality documentation which is complete and compliant to support qualification activities. Development of Quality Audit Programme to monitor compliance throughout the project. Basic Design Detail Design Procurement Construction C&Q

8 Validation Approach A risk-based approach with a combination of Good Engineering Practices (GEP), corporate guidelines and adherence to regulatory requirements. V-Model Risk Based Verification Reference: The V-Model for direct Impact systems From ISPE, V-model for direct impact systems, in Commissioning and Qualification Baseline Pharmaceutical Engineering Guide, Vol. 5 1 st ed. International Society for Pharmaceutical Engineering, March 2001 Reference: The Specification, Design and Verification Process Figure 1 ASTM E Standard Guide for Specification, Design and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment, pg 3 Basic Design Detail Design Procurement Construction C&Q

9 Project Life Cycle / C&Q Deliverables Basic Design Detail Design Procurement Construction C&Q GMP Design 30% and 60% Review System List Boundary Limits Regulatory Statement / Assessment Initial GMP Report GMP Design Review 90% GMP Review Report Risk Assessment Qualification Matrix QMP / VMP URS/ FRS DQ Vendor Audit Vendor Qualification Review / Approve vendor s VDR and PQP FAT SAT Quality Plan Vendor Turn over package Cx execution IQ execution OQ execution PQ execution CQV Reports

10 GMP Design Review The GMP Review is the documented examination/audit at timely interval during the design phase, that the design of the facilities, systems and equipment is suitable for the intended purpose and published GMP. Ensure that compliance requirements are adequately addressed by the proposed design. Topics typically include: - Facility / premises Controlled environment area HVAC Personnel / material flow Waste management Equipment Automation / computerized system Basic Design Detail Design Procurement Construction C&Q

11 Validation Master Plan (VMP) The purpose of this is to define the format for the preparation of the Validation Master Plan (VMP) that summarises the firm's overall validation philosophy, intentions and approach to be used for establishing performance adequacy. Common Content: Validation team organisation / Responsibility Qualification/Validation Documents Required Facility/Product/Process Description Qualification / Validation Approach Risk Assessment General Acceptance Criteria Change Control procedure Revalidation consideration Quality support program Engineering support program Regulatory Requirement and Standard Basic Design Detail Design Procurement Construction C&Q

12 Design Qualification Documented verification that the design of the utilities, equipment or systems is suitable for the intended purpose. Deliverables Samples: User Requirement Specification Design Specification Functional specification Block Diagram Process Flow Diagram Job Specification (Automation) Hardware Design Specification Software Design Specification Equipment Layout Room Data Sheets Personnel Flow Plan Material Flow Plan Architectural Plan GMP Zoning Plan Basic Design Detail Design Procurement Construction C&Q

13 Project Flow Basic Design Detail Design Procurement Construction C&Q

14 Commissioning and Qualification Phase Basic Design Detail Design Procurement Construction C&Q

15 Installation Qualification Documented verification that a system is installed according to written and pre-approved specifications. Deliverables Samples: Installation Verification Design Verification Critical Instrument List Non-Critical Instrument List Drawings Manuals Recommended Spare Parts and Consumable List Purchase Orders Environmental Conditions Safety Inspection Calibration Preventive Maintenance Documentation Wiring Basic Design Detail Design Procurement Construction C&Q

16 Operational Qualification Documented verification that a system operates according to the written and pre-approved specifications throughout all specified operating ranges. Test Samples: Written Procedure Verification Training Documentation Validation Test Equipment Calibration Utilities Testing Operator panel Verification Environmental Test Alarm Verification Security and Access Electromagnetic Interference Test Radio Frequency Interference Test Power Failure and Recovery Test Back-up Procedure Verification Operational Testing Protocol Deviation Investigation Form Basic Design Detail Design Procurement Construction C&Q

17 Vendor Turn Over Package Production Data Book (PDB) Mechanical Catalogue (MC) Quality Control Dossier (QCD) Mechanical Construction and Commissioning Dossier(MCCD) Basic Design Detail Design Procurement Construction C&Q

18 GMP Audit Purpose is to evaluate GMP compliance status of the manufacturer in accordance with the current GMP requirements On-site assessment using systematic, independent and documented process for obtaining evidence and evaluating it objectively to determine the extent to which criteria are fulfilled. Benefits : Effective assessment of GMP Compliance Reduced costs Improved performance Facilitate harmonised guidelines for auditing Increased external confidence Inspection readiness

19 GMP Audit General Org & Management responsibilities, Employee orientation and training, Plant safety and security, Internal quality program Facility Design and Layout, Environmental control, Maintenance and Good Housekeeping Program, External contractor Control Equipment Design and Placement, Identification, Maintenance and Cleaning, Calibration program, Qualification program Material / Component Specification and Purchasing control, Receipt, Inspection, Sampling and Lab Testing, Storage and Handling, Inventory Control, Supplier Control Operational Material/ Component / Label Verification, Storage and Handling, Equipment/Line/Area Cleaning, Preparation and Clearance, Operational Process Validation and Production Change Order Control, In-process Inspection, Sampling and Laboratory Control, reprocessing/disposition of materials Finished Products Verification, Storage and Handling, Inspection, Sampling, Testing and release for distribution, Distribution control, Complaint handling and customer satisfaction program

20 Summary Basic Design Detail Design Procurement Construction C&Q GMP Design 30% and 60% Review System List Boundary Limits Regulatory Statement / Assessment Initial GMP Report GMP Design Review 90% GMP Review Report Risk Assessment Qualification Matrix QMP /VMP URS / FRS DQ Vendor Audit Vendor Qualification Review/ Approve vendor s VDR and PQP FAT SAT Quality Plan Vendor Turn over package Cx execution IQ execution OQ execution PQ execution CQV Reports GMP Compliance must be incorporated in the project from Day 1 M+W has the in house ability to assess these requirements and ensure compliance. We offer a one stop solution.

21 What we can offer Consulting Design Construction Operation Auditing GMP Compliance Review Qualification/Validation Design Review Design Qualification Project / Construction- Management Schedule QA / QC Commissioning & Start-up Process Support / Operational Qualification Performance Qualification Installation / Operational Qualification Additional Consultancy and Support Service: GMP Training and Audits Quality Management System preparation Cleaning Validation Support for Process Validation Preparation of SOPs and delivery of associated training

22 M+W Life Sciences Capabilities We deliver one stop shop solutions for the Life Sciences Industry - from initial Site selections and Feasibility studies, to Concept/ Basic/ Detail Design moving into Construction and last but not least Commissioning/ IQ/ OQ as well as Validation - in short the whole project Life cycle Qualification / Validation Project Management & Construction Consultation / Engineering

23 If you think compliance is expensive, try noncompliance. -Former Deputy US Attorney General Paul McNulty

24 Thank You. George Acevedo CQV Senior Engineer M+W Singapore Pte. Ltd. A Company of the M+W Group 16 International Business Park #02-00 Singapore DID: SG Mobile: george.acevedo@mwgroup.net

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

Validation Boot Camp. Validation Fundamentals: Conducting a Successful Validation Project

Validation Boot Camp. Validation Fundamentals: Conducting a Successful Validation Project Validation Boot Camp Validation Fundamentals: Conducting a Successful Validation Project Learning Objectives Upon completion of this workshop, participants will be able to: Understand FDA and GMP terms

More information

Validation Boot Camp. Validation Fundamentals: Conducting a Successful Validation Project

Validation Boot Camp. Validation Fundamentals: Conducting a Successful Validation Project Validation Boot Camp Validation Fundamentals: Conducting a Successful Validation Project Learning Objectives Upon completion of this workshop, participants will be able to: Understand FDA and GMP terms

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND

More information

Managing Validation. Paperless Recorders

Managing Validation. Paperless Recorders Managing Validation Paperless Recorders Multitrend Plus Validation Background The past five years has seen an increase in the use of computerized systems and products in the pharmaceutical and bio-pharmaceutical

More information

Latino America Consultores Innovation & Technology to make your Business Compliant

Latino America Consultores Innovation & Technology to make your Business Compliant Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

MASTER PLANNING FOR VALIDATION

MASTER PLANNING FOR VALIDATION MASTER PLANNING FOR VALIDATION By: Gamal Amer, Ph.D. Principal, Premier Compliance Services, Inc. 1 Process Validation: General Principles and Practices Guidance to industry issued by the FDA in January

More information

Design and Construction of Biocontainment Laboratories

Design and Construction of Biocontainment Laboratories Design and Construction of Biocontainment Laboratories Commissioning and Validation Benjamin MABILE Director Global Validation, GSK Biologicals GSK Biologicals Context - Vaccines Key elements of the Validation

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

Validation Documentation. Presented by John Montalto 27 March, 2013

Validation Documentation. Presented by John Montalto 27 March, 2013 Validation Documentation Presented by John Montalto 27 March, 2013 Validation planning Validation policies define management intent and commitment Validation Master Plans (VMPs) Individual Validation Plans

More information

GAMP5 Validation for Dynamics 365

GAMP5 Validation for Dynamics 365 GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning

More information

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA Implement Effective Computer System Validation Noelia Ortiz, MME, CSSGB, CQA Session Outline 1 2 3 4 5 Understanding Regulations and Guidelines Pertaining to Computer Systems Integrate SDLC and GAMP 5

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt Validation Services SESSION 14 Documentation Requirements and Management for Validation 30 March 2017 Frits Vogt fritsvogt@valserv.nl Content Documentation Requirements and Management for Validation I.

More information

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago (UIC) College of Pharmacy, Chicago,

More information

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP May 1-3, 2012 Javits Center New York, NY Introduction to ISPE GUIDE: SCIENCE AND RISK-BASED APPROACH FOR THE DELIVERY OF FACILITIES, SYSTEMS, AND EQUIPMENT & Overview of Amgen s CQP Commissioning and Qualification

More information

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES William Garvey and Associates LLC 2016 Introduction About your instructor William (Bill) Garvey Important regulations and events Good Manufacturing

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

VALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY

VALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY VALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY Oren Levin, Diane Gordon VisionCare Ophthalmic Technologies, POB 3879, Petah Tikva 49130,

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

Contents. Contents (13) 1 Qualification (21)

Contents. Contents (13) 1 Qualification (21) 1 Qualification (21) 1.A Official requirements (23) 1.A.1 Legal aspects of qualification (23) 1.A.2 Documentation of the qualification (26) 1.A.3 Design Qualification (DQ) (27) 1.A.4 Installation Qualification

More information

Process development and basic GMP

Process development and basic GMP Process development and basic GMP Aulton Chapter 45, handouts Specification, stability, inprocess controls and validation Product development Process development Critical Product Qualities issues Critical

More information

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Longe Sunday Anthony Head- Quality Assurance May & Baker Nigeria Plc. Pharmacentre, Ota, Nigeria eaglesconsult@gmail.com; Slonge@may-

More information

T H E P R O P O S A L F O R T H E Y E A R

T H E P R O P O S A L F O R T H E Y E A R Training T H E P R O P O S A L F O R T H E Y E A R 2 0 1 9 Our GMP courses combine a convenient format with an effective, interactive learning experience. To maximize and customize your professional development.

More information

According to USP <1058>

According to USP <1058> Analytical l Instrument t Qualification According to USP Scope, Approach, Requirements Dr. Ludwig Huber Chief Advisor, Global FDA Compliance ludwig_huber@labcompliance.com Overview FDA and International

More information

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION Pharmapathway.com SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION Page 1 of 43 1. INTRODUCTION Validation is an essential and integral part of Good Manufacturing Practice (GMP).

More information

Manual 069 The validation of facilities and system

Manual 069 The validation of facilities and system 1. Purpose The purpose of this guideline is to provide requirements for the Validation of Facilities and Systems and to outline recommendations on how to achieve compliance. 2. Scope This guideline can

More information

Library Guide: Active Pharmaceutical

Library Guide: Active Pharmaceutical Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the

More information

Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation

Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation 29 May 2014 EUROPEAN COMMISSION Health and Consumers Directorate-General Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification

More information

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Validation An International Perspective

Validation An International Perspective Validation An International Perspective Agenda Perceived industry problems - From QTPP/PQA Process Validation Paradigm shifts Process Validation based on QbD, Design Space, etc. Incremental changes Plain

More information

Good manufacturing practices

Good manufacturing practices ORIGINAL PAPER 1AR-10 ISBT Science Series (2009) 4, 6 10 Journal compilation 2009 International Society of Blood Transfusion Good manufacturing practices Blackwell Publishing Ltd A. Ahmed Quality Manager,

More information

Developing an Internal Quality Auditing Program

Developing an Internal Quality Auditing Program Developing an Internal Quality Auditing Program SeerPharma Pty Lt Capsig August 2009 1 Critical Success Factors Culture of Compliance Integrate quality systems and risk management principles Well defined

More information

Risk Based Validation. Why, How and with what tools?

Risk Based Validation. Why, How and with what tools? Risk Based Validation Why, How and with what tools? Tech Talk Agenda History of FDA GMP initiative for the 21 st Century. Industry response to FDA initiative. Harmonisation through ICH. ASTM Standard on

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

The procurement, qualification and calibration of lab instruments: An Overview

The procurement, qualification and calibration of lab instruments: An Overview The procurement, qualification and calibration of lab instruments: An Overview The reliability of analytical data generated from chemical and physical analyses is critically dependent on three factors:

More information

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT API Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Part 1: General information Name of Manufacture Unit number

More information

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline

More information

Develop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017

Develop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017 Develop a Roadmap for the Implementation of a Global CSV Program Eileen Cortes April 26, 2017 Agenda CSV Regulation Principles CSV Lifecycle Approach CSV and Quality Management Governance Program and CSV

More information

Supplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4.

Supplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4. Supplementary Training Modules on Good Manufacturing Practice Validation WHO Technical Report Series, No. 937, 2006. Annex 4. Validation Slide 1 of 48 August 2006 Validation! Part 1. General overview on

More information

Project QMS and Quality by Design Activities

Project QMS and Quality by Design Activities QMS and Quality by Design Activities Main Topics of the Presentation Quality by Design Structure Critical Control Points in the Different Phases 1. Acquisition Phase 2. Design and Engineering Phase 3.

More information

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms Organized

More information

GAMP Guideline & Validation Documentation

GAMP Guideline & Validation Documentation GAMP Guideline & Validation Documentation Danilo Maruccia Milano, 21 Marzo 2006 GAMP Guideline & Validation Documentation GAMP Guideline Planning documents Specification Documents Testing Documents Acceptance

More information

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer

More information

Guidelines for validation and qualification, including change control, for hospital transfusion laboratories

Guidelines for validation and qualification, including change control, for hospital transfusion laboratories Transfusion Medicine GUIDELINES Guidelines for validation and qualification, including change control, for hospital transfusion laboratories British Committee for Standards in Haematology, Transfusion

More information

Annex Draft Annex

Annex Draft Annex Anmerkung 1: Dieses Vergleichsdokument wurde nach bestem Wissen und Gewissen erstellt und ist rechtlich nicht bindend. Es gelten die von der EMA veröffentlichten Dokumente in der jeweiligen Form. Anmerkung

More information

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance Testo Expert Knowledge The GxP Dictionary 1st edition Definitions relating to GxP and Quality Assurance Note: Some of the information contained in this GxP Dictionary does not apply equally to all countries.

More information

The long anticipated draft of the FDA s

The long anticipated draft of the FDA s This article provides an overview of the draft guidance, the key changes in relation to the 1987 guidance, and reviews its potential impact on the current industry approaches to science- and risk-based

More information

WARNING LETTER AUG 3, 2016

WARNING LETTER AUG 3, 2016 Ropack, Inc. 8/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration 10903 New Hampshire Avenue White Oak Building 66 Silver Spring, MD 20993 WARNING LETTER AUG

More information

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Prequalification of Medicines Programme SOP 408.4 Annex B WHO PUBLIC INSPECTION REPORT API Manufacturer Part 1: General information Name of Manufacturer Unit number WHO PUBLIC INSPECTION REPORT (WHOPIR)

More information

GMP On Site Series. GMP Essentials

GMP On Site Series. GMP Essentials GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history

More information

ISO13485: An Overview - Gunter Frey Member, SG3 NEMA

ISO13485: An Overview - Gunter Frey Member, SG3 NEMA ISO13485:2003 - An Overview - Member, SG3 NEMA Americas (FDA/CMDR) Regulatory Authorities Europe (Competent Authorities) A Global View India (AERB) Singapore (HSA) Thai FDA Malaysian Govt Russia (GHOST)

More information

Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance

Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance Bob Mauger, Principal Validation Consultant Cork, April 3/4 2003 Agenda Business System Compliance Overview

More information

Journal home page: RESEARCH ARTICLE

Journal home page:  RESEARCH ARTICLE Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;

More information

Qualification and validation: - an inspector s perspective. Ian Rees, Unit Manager Inspectorate Strategy

Qualification and validation: - an inspector s perspective. Ian Rees, Unit Manager Inspectorate Strategy Qualification and validation: - an inspector s perspective Ian Rees, Unit Manager Inspectorate Strategy GMP - basics A system within an organisation (or linked organisations) to assure the quality of its

More information

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago

More information

ICH Q10/WHO TRS A Regulatory Perspective

ICH Q10/WHO TRS A Regulatory Perspective Presentation by: Dr. A. Ramkishan Asst. Drugs Controller (India) Govt. of India ICH Q10/WHO TRS A Regulatory Perspective Contents of Presentation Introduction History of WHO GMP TRS guidelines A Unique

More information

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW 1.0 INTRODUCTION: The purpose of this guidance is to communicate the expectation with regard to the conduct of Product Quality Review. Product Quality

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

Regulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd.

Regulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. Regulatory Aspects of Cleaning and Cleaning Validation Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. 28 June 2017 Why clean? Pharmaceutical production equipment is cleaned

More information

GAMP 4/5 Prospective / retrospective Qualification of water treatment plants) P. Dony

GAMP 4/5 Prospective / retrospective Qualification of water treatment plants) P. Dony GAMP 4/5 Prospective / retrospective Qualification of water treatment plants) P. Dony 31.03.2008 Table of contents Slide 2 1. GAMP 4 and GAMP 5 differences 2. CHRIST prospective Qualification strategy

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

Process Validation (PV): Designing an Effective PV Program. Mike Porter Compliance Consultant Commissioning Agents Inc.

Process Validation (PV): Designing an Effective PV Program. Mike Porter Compliance Consultant Commissioning Agents Inc. Process Validation (PV): Designing an Effective PV Program Mike Porter Compliance Consultant Commissioning Agents Inc. (CAI) 24Apr2013 Agenda Process Validation Background Stage 1: Process Design Stage

More information

GMP Track 1 Day 2 Session 1 Vendor Assurance

GMP Track 1 Day 2 Session 1 Vendor Assurance GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics

More information

Anushri Global Pharma Consultants

Anushri Global Pharma Consultants Anushri Global Pharma Consultants Your Knowledge Partner In Training, Consulting & Placement Anushri Global Pharma Consultants A Catalyst to sustainable growth Page 1 of 9 About Us Training is important

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

HACCP audit checklist

HACCP audit checklist Requirement HACCP audit checklist Prerequisite Program Management Commitment 1. Senior management ensures that the responsibilities and authorities are defined and communicated within the company Internal

More information

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017 CSV Inspection Readiness through Effective Document Control Eileen Cortes April 27, 2017 Agenda Background CSV Readiness CSV and Change Management Process Inspection Readiness Do s and Don ts Inspection

More information

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Vijayasree et al. SJIF Impact Factor 6.647 Volume 6, Issue 3, 367-874 Review Article ISSN 2278 4357 PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL

More information

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES A Basic Overview: Meeting the PIC/S Requirements for a Computerized System Lynn Archambault Waters Corporation, Milford, MA, USA INTRODUCTION The Pharmaceutical Inspection Convention and Pharmaceutical

More information

Received: ; Accepted: ESSENTIALS OF QUALITY ASSURANCE

Received: ; Accepted: ESSENTIALS OF QUALITY ASSURANCE International Journal of Institutional Pharmacy and Life Sciences 2(2): March-April 2012 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Review Article!!! Pranshu

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

Validation of MES and Manufacturing Automation systems

Validation of MES and Manufacturing Automation systems Validation of MES and Manufacturing Automation systems The FDA Group Presentation APRIL 26, 2017 Chinmoy Roy, B.S. (Hons.) MSCS Industry Consultant 1 Agenda What is a MES Validation concepts Validation

More information

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference

More information

At Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.

At Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. At Your ServIce Microbiology Services The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. Microbiology Services Optimize your QC lab workflow and ensure regulatory compliance

More information

The World Bank. Aide Memoire for use during GMP inspections

The World Bank. Aide Memoire for use during GMP inspections The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address

More information

ANNEX 5 PRODUCT SPECIFICATIONS AND TECHNICAL REQUIREMENTS

ANNEX 5 PRODUCT SPECIFICATIONS AND TECHNICAL REQUIREMENTS ANNEX 5 PRODUCT SPECIFICATIONS AND TECHNICAL REQUIREMENTS This Document is to provide the offerors with the product(s) specifications and Technical Requirements for The Procurement of the commodities listed

More information

GMP & Quality Assurance. Mayur Sushir Dept of Microbiology MJC

GMP & Quality Assurance. Mayur Sushir Dept of Microbiology MJC GMP & Quality Assurance Mayur Sushir Dept of Microbiology MJC Introduction GMP ensures that quality is built into the organization & processes involved in manufacture GMP covers all aspects of manufacture

More information

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018 PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 045-1 1 July 2018 GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY D. VIJAY KUMAR, KAMESWARA RAO S., P. BHARGAVA BHUSHAN RAO, T. V. V.

More information

PURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015

PURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015 PURITAN PRODUCTS QUALITY OVERVIEW Quality Management System Self-Audit September 15, 2015 Founded in 1987, Puritan Products, Inc. is a cgmp compliant, FDA registered and inspected, and ISO-9001:2008 certified

More information

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852 22 January 2009 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 SUBMISSION OF COMMENTS, DOCKET NO. FDA-2008-D-0559 Dear Sir or Madam:

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Empaques Primarios y Tendencias Farmaceuticas para Inyectables 1 International Support Support in R&D Technology Transfer

More information

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation

More information

UNICEF Quality Assurance in the procurement of medicines

UNICEF Quality Assurance in the procurement of medicines UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen October 2008 Quality Assurance Centre SUPPLY DIVISION 2 Today s presentation addresses 3 questions: How do UNICEF manage quality

More information

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing

More information

How to Execute a Pharma Project to Meet US FDA / EMA Requirements

How to Execute a Pharma Project to Meet US FDA / EMA Requirements How to Execute a Pharma Project to Meet US FDA / EMA Requirements Double Dragon Consulting (DDC) 雙龍諮詢 George Bernstein, Ph.D. Principal Double Dragon Consulting Takeaway from this Talk The more familiar

More information

Process ERP, an ideal software solution for Life Science industries

Process ERP, an ideal software solution for Life Science industries Process ERP, an ideal software solution for Life Science industries Update on FDA's current compliance requirements of GxP regulated computerized systems Ravi Jotwani, Ph.D University of Louisville ProcessManufacturingSoftware

More information